[Clinical study for augmentation of efficacy of anticancer drugs. 1. Combination therapy by proteolytic enzyme and anticancer drugs].
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000378:metabolism; D001943:Breast Neoplasms / Q000188:drug therapy; D003110:Colonic Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000378:metabolism; D004357:Drug Synergism; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy; D010447:Peptide Hydrolases / Q000008:administration & dosage*; D012004:Rectal Neoplasms / Q000188:drug therapy; D013274:Stomach Neoplasms / Q000188:drug therapy; D013964:Thyroid Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D010447:Peptide Hydrolases